Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patien… (NCT03107299) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis
France98 participantsStarted 2016-07-05
Plain-language summary
Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence of this treatment decreases the control of the disease and the effectiveness of the associated treatments.
The aim would be to study the observance of patients with RA and to be able to propose adequate solutions favoring patient compliance and thus the stability of the pathology.
For this purpose, 3 methods of communication have been put in place to encourage adherence: usual care by the rheumatologist, sms sending or pharmaceutical maintenance.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients attending Day Hospital or consultation of rheumatology with rheumatoid polyarteritis and under treatment with MTX alone or in combination with another therapeutic, fixed dosage for at least 3 months.
* Consenting Patient
* Literate French-speaking patient,
* Patient with a mobile phone
* Patient affiliated to a social security scheme
Exclusion Criteria:
* Patient not managing his own treatment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared three different communication methods to help people stick to their methotrexate treatment — do you know which of those methods was found most effective, and could that approach be used in my care?
2Since this study is now completed, have the results been published, and if so, what did they show about why patients with rheumatoid arthritis struggle to take methotrexate consistently?
3The trial measured adherence using something called the CQR19 questionnaire — is that a tool you use in your practice, and could we use it to track how well I'm managing my methotrexate over time?
4Given that this research focused specifically on sticking to methotrexate, are there particular strategies — like reminders, educational sessions, or check-in calls — that you'd recommend to help me stay on track with my treatment?
5If adherence to methotrexate turns out to be a challenge for me, what alternatives or additional support options would you consider before changing my treatment plan entirely?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.